GLP-1 drugs linked to lower rates of some cancers July 16, 2024 Source: Wang, et al, JAMA Network Open, July 5, 2024 LINK Obesity is associated with increased risk of multiple cancers, including breast cancer, colorectal cancer, and endometrial cancer
Have you ever wondered how our bodies manage the constant assault of toxins, pollutants, and oxidative stress
While these medications are mainly associated with improved insulin sensitivity and weight loss, researchers are learning that the benefits of these GLP-1 drugs may go well beyond these effects
Data source In this study, information regarding the dispensed GLP-1 RA brand claimed benefit together with individual demographic and medical data were extracted from the health care data register VAL (Vrdanalysdatabaserna), a data warehouse governed by Region Stockholm which has previously been used in similar research [49, 50]